Table 1 MGSA Staining Characteristics in Melanocytic Nevi
From: Melanoma Growth Stimulatory Activity in Primary Malignant Melanoma: Prognostic Significance
Type of Melanocytic Nevi | Total | Staining Intensity | % Cells Immunostained | ||||
|---|---|---|---|---|---|---|---|
0 | 1 | 2 | 3 | ≤50 | >50 | ||
Melanocytic NEVI (31) | |||||||
Compound (junctional component) | 9 | 0 | 1 | 2 | 6 | 1 | 8 |
Compound (dermal component) | 9 | 4 | 0 | 2 | 3 | 8 | 1 |
Junctional | 3 | 0 | 0 | 1 | 2 | 0 | 3 |
Intradermal nevi | 19 | 9 | 0 | 6 | 4 | 17 | 2 |
Total | 31 | 25 | 14 | ||||
Dysplastic NEVI (23) | |||||||
Compound (junctional component) | 16 | 0 | 0 | 8 | 8 | 8 | 8 |
Compound (dermal component) | 16 | 3 | 2 | 11 | 0 | 11 | 5 |
Junctional nevi | 7 | 0 | 0 | 0 | 7 | 0 | 7 |
Total | 23 | 19 | 20 | ||||
